NBP Softgel Capsules

DRUG3 trials

Sponsors

CSPC-NBP Pharmaceutical Co., Ltd., Conjupro Biotherapeutics, Inc., Chinese PLA General Hospital

Conditions

AISBreast CancerMigrainePeripheral Neuropathy

Phase 2

NBP in Adult Patients With Acute Ischemic Stroke (AIS)

CompletedNCT02905565

CSPC-NBP Pharmaceutical Co., Ltd.AIS

Start: 2018-02-28End: 2020-08-07Updated: 2020-09-17

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

WithdrawnNCT04675450

Conjupro Biotherapeutics, Inc.Breast Cancer, Peripheral Neuropathy

Start: 2023-06-30End: 2025-01-30Updated: 2023-06-08

Unknown Phase

Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients

Not yet recruitingNCT06968429

Chinese PLA General HospitalMigraine

Start: 2025-05-31End: 2028-12-31Target: 500Updated: 2025-05-13

Related Papers

Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.

2022-08-197 citations